Triple
T19296726
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Beecham family |
E482583
|
entity |
| Predicate | mergedBusinessLegacyIn |
P38329
|
FINISHED |
| Object | GlaxoSmithKline |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: GlaxoSmithKline | Statement: [Beecham family, mergedBusinessLegacyIn, GlaxoSmithKline]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: GlaxoSmithKline Context triple: [Beecham family, mergedBusinessLegacyIn, GlaxoSmithKline]
-
A.
GlaxoSmithKline
chosen
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
B.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Merck KGaA
Merck KGaA is a German multinational science and technology company specializing in healthcare, life science, and electronics.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: mergedBusinessLegacyIn Context triple: [Beecham family, mergedBusinessLegacyIn, GlaxoSmithKline]
-
A.
administrationBaseAfterMerger
Indicates that an entity serves as the primary administrative base or headquarters of another entity following a merger.
-
B.
mergedOrReorganized
chosen
Indicates that one entity has combined with or been structurally reorganized into another entity, resulting in a changed or unified organizational form.
-
C.
mergedBy
Indicates that one entity is combined or integrated into another entity through the action or decision of a specific agent.
-
D.
mergerPartner
Indicates that two entities are involved as counterparties in a merger transaction with each other.
-
E.
mergerResultedIn
Indicates that a merger between entities led to the creation, change, or outcome represented by the related entity or state.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e8cf61b0819096fe3e4107827c4e |
completed | April 10, 2026, 12:10 p.m. |
| NER | Named-entity recognition | batch_69e5fc85e8988190a98bc291121f0153 |
completed | April 20, 2026, 10:14 a.m. |
| PD | Predicate disambiguation | batch_69e4dd0bc7508190a6f9d56bd4c3404f |
completed | April 19, 2026, 1:47 p.m. |
Created at: April 10, 2026, 1:31 p.m.